v3.22.0.1
FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2021
FAIR VALUE MEASUREMENTS  
FAIR VALUE MEASUREMENTS

NOTE 12—FAIR VALUE MEASUREMENTS

Fair value refers to the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the entity transacts business. The inputs used to develop these fair value measurements are established in a hierarchy, which ranks the quality and reliability of the information

used to determine the fair values. The fair value classification is based on levels of inputs. Assets and liabilities that are carried at fair value are classified and disclosed in one of the following categories:

Level 1:

Quoted market prices in active markets for identical assets or liabilities.

Level 2:

Observable inputs that are corroborated by market data.

Level 3:

Unobservable inputs that are not corroborated by market data.

Recurring Fair Value Measurements. The following tables summarize the fair value hierarchy of the Company’s financial assets carried at fair value on a recurring basis:

Fair Value Measurements at December 31, 2021 Using

Significant

    

Total Carrying

    

Quoted prices in

    

Significant other

    

unobservable

Value at

active market

observable inputs

inputs

(In millions)

December 31, 2021

(Level 1)

(Level 2)

(Level 3)

Other long-term assets:

Money market mutual funds

$

0.5

$

0.5

$

$

Investments measured at net asset value(1)

12.4

 

 

 

Total assets at fair value

$

12.9

$

0.5

$

$

Fair Value Measurements at December 31, 2020 Using

Significant

    

Total Carrying

    

Quoted prices in

    

Significant other

    

unobservable

Value at

active market

observable inputs

inputs

(In millions)

December 31, 2020

(Level 1)

(Level 2)

(Level 3)

Other long-term assets:

Money market mutual funds

$

1.1

$

1.1

$

$

Investments measured at net asset value(1)

10.6

Marketable equity securities:

Investment in NCM

5.2

5.2

Total assets at fair value

$

16.9

$

6.3

$

$

(1)The investments relate to non-qualified deferred compensation arrangements on behalf of certain members of management. The Company has an equivalent liability for this related-party transaction recorded in other long-term liabilities for the deferred compensation obligation. The plan was terminated on May 3, 2021 and will be liquidated in 2022.

Valuation Techniques. The Company’s money market mutual funds are invested in funds that seek to preserve principal, are highly liquid, and therefore are recorded on the balance sheet at the principal amounts deposited, which equals fair value.

Nonrecurring Fair Value Measurements. The following fair value hierarchy tables summarize the Company’s assets that were written down to their fair value on a nonrecurring basis:

Fair Value Measurements at December 31, 2021 Using

    

    

Significant other

    

Significant

 

    

Total Carrying

Quoted prices in

observable

unobservable

Value at

active market

inputs

inputs

Total

(In millions)

    

December 31, 2021

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

Losses

Property, net:

Property net

$

22.8

$

$

$

22.8

$

21.8

Operating lease right-of-use assets, net

Operating lease right-of-use assets, et

99.2

99.2

53.4

Other long-term assets

Property owned, net

2.0

2.0

2.0

Total

$

124.0

$

$

$

124.0

$

77.2

Fair Value Measurements Using

    

    

Significant other

    

Significant

 

    

Total Carrying

Quoted prices in

observable

unobservable

Value at

active market

inputs

inputs

Total

(In millions)

    

Measurement Date

Measurement Date

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

Losses

Property, net:

Property net

March 31, 2020

$

40.5

$

$

$

40.5

$

30.9

Property net

September 30, 2020

14.3

14.3

8.5

Property net

December 31, 2020

25.4

25.4

20.7

Operating lease right-of-use assets

Operating lease right-of-use assets

March 31, 2020

124.0

124.0

60.4

Operating lease right-of-use assets

September 30, 2020

56.8

56.8

19.6

Operating lease right-of-use assets

December 31, 2020

69.0

69.0

37.8

Intangible assets, net

Definite-lived intangible assets

March 31, 2020

6.6

6.6

8.0

Indefinite-lived intangible assets

March 31, 2020

50.3

50.3

8.3

Definite-lived intangible assets

September 30, 2020

6.4

Indefinite-lived intangible assets

September 30, 2020

43.8

43.8

4.6

Indefinite-lived intangible assets

December 31, 2020

44.0

44.0

2.3

Goodwill

Goodwill

March 31, 2020

2,938.0

2,938.0

1,744.3

Goodwill

September 30, 2020

2,874.4

2,874.4

156.8

Goodwill

December 31, 2020

2,547.3

2,547.3

405.3

Other long-term assets

Cost method investments

March 31, 2020

7.2

Cost method investments

December 31, 2020

11.3

11.3

8.7

Equity method investments

December 31, 2020

17.2

17.2

8.6

Total

$

8,862.9

$

$

$

8,862.9

$

2,538.4

Valuation Techniques. There is considerable management judgment with respect to cash flow estimates and appropriate discount rates to be used in determining fair value, and, accordingly, actual results could vary significantly from such estimates, which fall under Level 3 within the fair value measurement hierarchy. Such judgments and estimates include estimates of future attendance, revenues, cash flows, rent relief, cost savings, capital expenditures, and the cost of capital, among others. At December 31, 2021, related cash flows were discounted at 10.0% for the Domestic Theatres and 11.5% for the International Theatres, at December 31, 2020, related cash flows were discounted at 11.0% for Domestic Theatres and 12.5% for International Theatres, at September 30, 2020, related cash flows were discounted at 12.0% for Domestic Theatres and 13.0% for International Theatres, and at March 31, 2020, related cash flows were discounted at 11.5% for Domestic Theatres and 13.0% for International Theatres. The Company used a long-term growth rate input of 1.0%, except for the March 31, 2020 measurement date, which the Company used a long-term growth rate input of 2.0%. These estimates determine whether impairments have been incurred and quantify the amount of any related impairment charge.

To estimate fair value of the Company’s indefinite-lived trade names, the Company employed a derivation of the Income Approach known as the Royalty Savings Method. The Royalty Savings Method values an intangible asset by estimating the royalties saved through ownership of the asset. The Company applied royalty rates of 0.5% for AMC and Odeon trade names and 1.0% for Nordic trade names to the related theatre revenues on an after-tax basis using effective tax rates. At December 31, 2020, related cash flows were discounted at 12.0% for AMC and 13.5% for Odeon and

Nordic, at September 30, 2020, related cash flows were discounted at 13.0% for AMC and 14.0% for Odeon and Nordic, and at March 31, 2020, related cash flows were discounted at 12.5% for AMC and 14.0% for Odeon and Nordic.

The Company performed the Step 1 quantitative goodwill impairment test as of March 31, 2020, September 30, 2020, and December 31, 2020. In performing the Step 1 quantitative goodwill impairment test, the Company used an enterprise value approach to measure fair value of the reporting units. In calculating the fair value of our Domestic Theatres and International Theatres reporting units by use the income approach for enterprise valuation methodology, which utilizes discounted cash flows. The income approach provides an estimate of fair value by measuring estimated annual cash flows over a discrete projection period and applying a present value discount rate to the cash flows. The present value of the cash flows is then added to the present value equivalent of the residual value of the business to arrive at an estimated fair value of the reporting unit. At December 31, 2020, related cash flows were discounted at 11.0% for Domestic Theatres and 12.5% for International Theatres, at September 30, 2020, related cash flows were discounted at 12.0% for Domestic Theatres and 13.0% for International Theatres, and at March 31, 2020, related cash flows were discounted at 11.5% for Domestic Theatres and 13.0% for International Theatres. The Company used a long-term growth rate input of 1.0%, except for the March 31, 2020 measurement date, which the Company used a long-term growth rate input of 2.0%.

Other Fair Value Measurement Disclosures. The following tables summarize the fair value of financial instruments that are not recognized at fair value in the statement of financial position for which it is practicable to estimate that value:

    

Fair Value Measurements at December 31, 2021 Using

    

    

Significant other

    

Significant

Total Carrying

Quoted prices in

observable

unobservable

Value at

active market

inputs

inputs

(In millions)

December 31, 2021

(Level 1)

(Level 2)

(Level 3)

Current maturities of corporate borrowings

$

20.0

$

$

18.1

$

Corporate borrowings

 

5,408.0

 

 

4,263.5

681.4

    

Fair Value Measurements at December 31, 2020 Using

    

    

Significant other

    

Significant

Total Carrying

Quoted prices in

observable

unobservable

Value at

active market

inputs

inputs

(In millions)

December 31, 2020

(Level 1)

(Level 2)

(Level 3)

Current maturities of corporate borrowings

$

20.0

$

$

12.9

$

Corporate borrowings

 

5,695.8

 

 

2,485.9

 

278.0

Valuation Technique. Quoted market prices and observable market based inputs were used to estimate fair value for Level 2 inputs. The Level 3 fair value measurement represents the transaction price of the corporate borrowings under estimated market conditions. The Company valued these notes at principal value less an estimated discount reflecting a market yield to maturity. See Note 8Corporate Borrowings and Finance Lease Obligations for further information.

The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities approximate fair value because of the short maturity of these instruments.